Sort
15,440 grants matching “organoids”
Elucidating Novel APE1 Redox-Dependent Functions in Esophageal Adenocarcinoma
$414,010Wael El-Rifai · University Of Miami School Of Medicine · P01 · FY2022 · CA
The role of PUMA in the progression of cigarette smoking-induced COPD
$413,958Dongshi Chen · University Of Southern California · R56 · FY2023 · HL
Anatomic and functional characterization of the intestinal crypt-villus niche
$413,878Ramesh A Shivdasani · Dana-Farber Cancer Inst · U01 · FY2019 · DK
How Vitamin D Receptor Influences Intestinal Barrier Functions
$413,719Jun Sun · University Of Illinois At Chicago · R01 · FY2020 · DK
The Development of First-in-Class Inhibitors of Oncogenic CHD1L for the Treatment of Colorectal Cancer.
$413,649Daniel V. Labarbera · University Of Colorado Denver · R01 · FY2022 · CA
Deep learning based 3D network biology knowledge portal for precision oncology
$413,509Haiyuan Yu · Cornell University · U01 · FY2025 · CA
Project 1: Human tissue models to study infectious diseases: Human 2D and 3D neural cultures for studying virus tropism and infection phenotypes.
$413,468Lee Gehrke · Massachusetts Institute Of Technology · U19 · FY2017 · AI
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
$413,407Janet L Stein · University Of Vermont & St Agric College · P01 · FY2025 · CA
The Role of Cancer-Associated Fibroblasts in Thyroid Carcinoma
$413,396Vivian Lee Weiss · Vanderbilt University Medical Center · R01 · FY2022 · CA
FFRDC MOONSHOT PORTFOLIO TASK ORDER - CRISPR gRNA Reagents for NGCMs
$413,303Christine Siemon · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Role of Receptor Tyrosine Kinase cross-talk in colorectal cancer
$413,293Bhuminder Singh · Vanderbilt University Medical Center · R01 · FY2024 · CA
Perinatal Dysbiosis, Lung Development and Asthma
$413,249Ian Paul Lewkowich · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers
$413,248Joseph Edward Willis · Case Western Reserve University · P50 · FY2017 · CA
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy
$413,191Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$413,053Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$413,053Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$413,053Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
Intestinal Lymphocyte Trafficking
$413,007Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2023 · AI
Identifying a protective role for interferon lambda in tuberculosis
$413,002Joshua T. Mattila · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · AI
ATR inhibitor-mediated reversal of PARP inhibitor resistance in high-grade serous ovarian cancer (HGSOS)
$412,977Geoffrey I Shapiro · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Autophagy-mediated defense against inflammation and cancer
$412,961Chengyu Liang · Wistar Institute · R01 · FY2024 · CA
Role of Metallothionein 1 E in the Protection of Cystic Fibrosis-Related Diabetes
$412,798Xiangming Ji · Pennsylvania State University, The · R01 · FY2025 · DK